Workflow
AstraZeneca earnings beat expectations as steady drug sales boost revenues
AstraZenecaAstraZeneca(US:AZN) Invezz·2024-04-25 11:41

AstraZeneca plc today, on April 25, announced its earnings report for the first quarter of FY24. Are you looking for signals & alerts from pro-traders? Sign-up to Invezz Signals™ for FREE. Takes 2 mins.Total Revenue increased by 19% to $ 12,679 million, driven by an 18% increase in product sales and continued growth in Alliance Revenue from partnered medicines. Core EPS increased 13% to $2.06. The increase in Core EPS was lower than total revenue growth mainly because of a $241m gain in the previous year’s ...